[{"orgOrder":0,"company":"Lithuanian Sports University","sponsor":"Kappa Bioscience | LSMU Kauno ligonine","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2021","type":"Inapplicable","leadProduct":"Vitamin K2","moa":"Trypanosoma Cruzipain (Trypano CYSP)","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Lithuanian Sports University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Oral Tablet","sponsorNew":"Lithuanian Sports University \/ Kappa Bioscience | LSMU Kauno ligonine","highestDevelopmentStatusID":"1","companyTruncated":"Lithuanian Sports University \/ Kappa Bioscience | LSMU Kauno ligonine"},{"orgOrder":0,"company":"University of Glasgow","sponsor":"Kappa Bioscience","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2020","type":"Inapplicable","leadProduct":"Vitamin K2","moa":"Trypanosoma Cruzipain (Trypano CYSP)","graph1":"Immunology","graph2":"Undisclosed","graph3":"University of Glasgow","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Glasgow \/ Kappa Bioscience","highestDevelopmentStatusID":"1","companyTruncated":"University of Glasgow \/ Kappa Bioscience"},{"orgOrder":0,"company":"Canisius-Wilhelmina Hospital","sponsor":"Kappa Bioscience","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2021","type":"Inapplicable","leadProduct":"Vitamin K2","moa":"Trypanosoma Cruzipain (Trypano CYSP)","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Canisius-Wilhelmina Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Canisius-Wilhelmina Hospital \/ Kappa Bioscience","highestDevelopmentStatusID":"1","companyTruncated":"Canisius-Wilhelmina Hospital \/ Kappa Bioscience"},{"orgOrder":0,"company":"Dasman Diabetes Institute","sponsor":"Kappa Bioscience","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2022","type":"Inapplicable","leadProduct":"Vitamin K2","moa":"Trypanosoma Cruzipain (Trypano CYSP)","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Dasman Diabetes Institute","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Dasman Diabetes Institute \/ Kappa Bioscience","highestDevelopmentStatusID":"1","companyTruncated":"Dasman Diabetes Institute \/ Kappa Bioscience"},{"orgOrder":0,"company":"NIZO Food Research","sponsor":"Kappa Bioscience","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2023","type":"Inapplicable","leadProduct":"Vitamin K2","moa":"Trypanosoma Cruzipain (Trypano CYSP)","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"NIZO Food Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Oil","sponsorNew":"NIZO Food Research \/ Kappa Bioscience","highestDevelopmentStatusID":"1","companyTruncated":"NIZO Food Research \/ Kappa Bioscience"},{"orgOrder":0,"company":"Sola Aoun Bahous, M.D. Ph.D.","sponsor":"Lesaffre International | Omicron Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2023","type":"Inapplicable","leadProduct":"Vitamin K2","moa":"Trypanosoma Cruzipain (Trypano CYSP)","graph1":"Neurology","graph2":"Undisclosed","graph3":"Sola Aoun Bahous, M.D. Ph.D.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Sola Aoun Bahous, M.D. Ph.D. \/ Lesaffre International | Omicron Pharmaceuticals","highestDevelopmentStatusID":"1","companyTruncated":"Sola Aoun Bahous, M.D. Ph.D. \/ Lesaffre International | Omicron Pharmaceuticals"}]

Find Clinical Drug Pipeline Developments & Deals for MK4

MK4
Drugs in Dev.
Full Screen View

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check COS database
Check all USDMF suppliers

Contact Us
PharmaScopic.com

MK4

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 1 USDMF, 3 JDMF, 1 EU WC, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

FINISHED DOSAGE FORMULATIONS

10 FDF Dossiers, 10 Listed Dossiers

MARKET PLACE

5 APIs, 2 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 JP

1 JP

Xls

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Sola Aoun Bahous, M.D. Ph.D.

Country

ChemOutsourcing

Not Confirmed

02

NIZO Food Research

Country

ChemOutsourcing

Not Confirmed

03

Dasman Diabetes Institute

Country

ChemOutsourcing

Not Confirmed

04

Lithuanian Sports University

Country

ChemOutsourcing

Not Confirmed

05

Canisius-Wilhelmina Hospital

Country

ChemOutsourcing

Not Confirmed

06

University of Glasgow

Country

ChemOutsourcing

Not Confirmed

07

Hopital St. Georges, Ajaltoun

Country

ChemOutsourcing

Not Confirmed

08

Lebanese American University

Country

ChemOutsourcing

Not Confirmed

09

University of Aarhus

Country

ChemOutsourcing

Not Confirmed

10

Danisco

Country

ChemOutsourcing

Not Confirmed